Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer Patients

NCT03278015 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Cancer of Pancreas

Interventions

DRUG: Nab-paclitaxel plus Gemcitabine
DRUG: Gemcitabine monotherapy
DRUG: S-1 monotherapy

Sponsor

Chinese PLA General Hospital